Caring Brands, INC 8-K filings

Caring Brands, Inc. has appointed Brian R. Meadows as its new Chief Financial Officer and amended its consulting services agreement with Myall Luna Ventures Inc., increasing the monthly fee.

Caring Brands, Inc. reports on a subsequent closing of its private placement, raising $2.55 million and bringing total gross proceeds to $7.15 million, with pro forma stockholders' equity exceeding Nasdaq's minimum requirement.

Caring Brands, Inc. announced the appointment of Brian R. Meadows as a director and entered into a consulting agreement for financial and accounting management services.

Caring Brands, Inc. has completed an initial closing of $4.6 million under a $9 million private placement, with proceeds earmarked for sales and marketing campaigns.

Caring Brands, Inc. announced the initial closing of a private placement, raising $4.6 million in gross proceeds and providing an estimated $5.85 million in stockholders' equity, aiding Nasdaq listing compliance.

Caring Brands, Inc. has entered into a Securities Purchase Agreement to issue Series B Convertible Preferred Stock and Warrants to accredited investors, raising up to $11 million.

Caring Brands Inc. announced the issuance of five U.S. patents protecting its Hair Enzyme Booster and Photocil product platforms, reinforcing its commercialization strategy.

Caring Brands, Inc. received a delisting determination from Nasdaq due to insufficient stockholders' equity and failure to secure additional financing.

Caring Brands, Inc. announced a private investment in public equity (PIPE) offering, issuing Series A Convertible Preferred Stock and Common Stock Purchase Warrants.

Caring Brands, Inc. announced the approval of three significant proposals by its stockholders at a Special Meeting held on July 9, 2026, including an additional investment right and share issuance.

Caring Brands Inc. has announced an expanded multi-territory licensing agreement with SanPellegrino Cosmetics Private Limited for its Photocil and Hair Enzyme Booster products, extending commercial reach across India, LATAM, Russia, Australia, and New Zealand.

Caring Brands, Inc. issued an 8-K to correct an inadvertent error regarding the record date for its upcoming annual meeting of stockholders.

Caring Brands, Inc. received a delisting warning from Nasdaq due to insufficient stockholders' equity, with 45 days to submit a compliance plan.

Caring Brands, Inc. announced an amendment to its bylaws reducing the shareholder meeting quorum and appointed Brian John as Interim Chief Financial Officer.

Caring Brands, Inc. completed a $3.6 million private placement of convertible preferred stock and warrants, using a significant portion to repurchase shares from its CEO, Chairman, and NovoDX, Inc.

Caring Brands Inc. announced the issuance of two new U.S. patents strengthening its Hair Enzyme Booster technology and intellectual property portfolio.

Caring Brands, Inc. announced the resignation of its Chief Financial Officer, Tyler Moore, effective January 5, 2026, with a search for a successor underway.

Caring Brands Inc. has entered an exclusive worldwide license agreement with Itonis Pharmaceuticals to manufacture, market, and sell the homeopathic Emesyl product.

Caring Brands, Inc. successfully closed its $4 million underwritten public offering and commenced trading on the Nasdaq Capital Markets under the symbol CABR.